|
1
|
Cenciarini M, Valentino M, Belia S, Sforna
L, Rosa P, Ronchetti S, D'Adamo MC and Pessia M: Dexamethasone in
glioblastoma multiforme therapy: Mechanisms and controversies.
Front Mol Neurosci. 12:652019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eisemann T, Costa B, Strelau J,
Mittelbronn M, Angel P and Peterziel H: An advanced glioma cell
invasion assay based on organotypic brain slice cultures. BMC
Cancer. 18:1032018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Babu R, Komisarow JM, Agarwal VJ,
Rahimpour S, Iyer A, Britt D, Karikari IO, Grossi PM, Thomas S,
Friedman AH and Adamson C: Glioblastoma in the elderly: The effect
of aggressive and modern therapies on survival. J Neurosurg.
124:998–1007. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Almenawer SA, Badhiwala JH, Alhazzani W,
Greenspoon J, Farrokhyar F, Yarascavitch B, Algird A, Kachur E,
Cenic A, Sharieff W, et al: Biopsy versus partial versus gross
total resection in older patients with high-grade glioma: A
systematic review and meta-analysis. Neuro Oncol. 17:868–881. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen J, Li Y, Yu TS, McKay RM, Burns DK,
Kernie SG and Parada LF: A restricted cell population propagates
glioblastoma growth after chemotherapy. Nature. 488:522–526. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bao S, Wu Q, Sathornsumetee S, Hao Y, Li
Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD and Rich JN: Stem
cell-like glioma cells promote tumor angiogenesis through vascular
endothelial growth factor. Cancer Res. 66:7843–7848. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kohler F and Rodriguez-Paredes M: DNA
methylation in epidermal differentiation, aging, and cancer. J
Invest Dermatol. 140:38–47. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lowrey PL and Takahashi JS: Mammalian
circadian biology: Elucidating genome-wide levels of temporal
organization. Annu Rev Genomics Hum Genet. 5:407–441. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ikegami K, Refetoff S, Van Cauter E and
Yoshimura T: Interconnection between circadian clocks and thyroid
function. Nat Rev Endocrinol. 15:590–600. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shostak A: Circadian clock, cell division,
and cancer: From molecules to organism. Int J Mol Sci. 18:E8732017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hwang-Verslues WW, Chang PH, Jeng YM, Kuo
WH, Chiang PH, Chang YC, Hsieh TH, Su FY, Lin LC, Abbondante S, et
al: Loss of corepressor PER2 under hypoxia up-regulates
OCT1-mediated EMT gene expression and enhances tumor malignancy.
Proc Natl Acad Sci USA. 110:12331–12336. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiang R, Cui Y, Wang Y, Xie T, Yang X,
Wang Z, Li J and Li Q: Circadian clock gene Per2 downregulation in
nonsmall cell lung cancer is associated with tumour progression and
metastasis. Oncol Rep. 40:3040–3048. 2018.PubMed/NCBI
|
|
15
|
Xiong H, Yang Y, Yang K, Zhao D, Tang H
and Ran X: Loss of the clock gene PER2 is associated with cancer
development and altered expression of important tumor-related genes
in oral cancer. Int J Oncol. 52:279–287. 2018.PubMed/NCBI
|
|
16
|
Deng F and Yang K: Current status of
research on the period family of clock genes in the occurrence and
development of cancer. J Cancer. 10:1117–1123. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu ML, Yeh KT, Lin PM, Hsu CM, Hsiao HH,
Liu YC, Lin HY, Lin SF and Yang MY: Deregulated expression of
circadian clock genes in gastric cancer. BMC Gastroenterol.
14:672014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mazzoccoli G, Panza A, Valvano MR, Palumbo
O, Carella M, Pazienza V, Biscaglia G, Tavano F, Di Sebastiano P,
Andriulli A and Piepoli A: Clock gene expression levels and
relationship with clinical and pathological features in colorectal
cancer patients. Chronobiol Int. 28:841–851. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rahman S, Kraljević Pavelić S and
Markova-Car E: Circadian (De)regulation in head and neck squamous
cell carcinoma. Int J Mol Sci. 20:E26622019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xia HC, Niu ZF, Ma H, Cao SZ, Hao SC, Liu
ZT and Wang F: Deregulated expression of the Per1 and Per2 in human
gliomas. Can J Neurol Sci. 37:365–370. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
23
|
Lv D, Ma QH, Duan JJ, Wu HB, Zhao XL, Yu
SC and Bian XW: Optimized dissociation protocol for isolating human
glioma stem cells from tumorspheres via fluorescence-activated cell
sorting. Cancer Lett. 377:105–115. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maiese K: Moving to the rhythm with clock
(circadian) genes, autophagy, mTOR, and SIRT1 in degenerative
disease and cancer. Curr Neurovasc Res. 14:299–304. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang J, Morita Y, Han B, Niemann S,
Löffler B and Rudolph KL: Per2 induction limits lymphoid-biased
haematopoietic stem cells and lymphopoiesis in the context of DNA
damage and ageing. Nat Cell Biol. 18:480–490. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Puram RV, Kowalczyk MS, de Boer CG,
Schneider RK, Miller PG, McConkey M, Tothova Z, Tejero H, Heckl D,
Järås M, et al: Core circadian clock genes regulate leukemia stem
cells in AML. Cell. 165:303–316. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ríos-Arrabal S, Muñoz-Gámez JA,
Jiménez-Ruíz SM, Casado-Ruíz J, Artacho-Cordón F and León-López J:
Circadian Regulation of Colon Cancer Stem Cells. Implications for
Therapy. 2016.
|
|
28
|
Zhang F, Sun H, Zhang S, Yang X, Zhang G
and Su T: Overexpression of PER3 inhibits self-renewal capability
and chemoresistance of colorectal cancer stem-like cells via
inhibition of notch and β-catenin signaling. Oncol Res. 25:709–719.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Miki T, Matsumoto T, Zhao Z and Lee CC:
p53 regulates period 2 expression and the circadian clock. Nat
Commun. 4:24442013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang X, He X, Yang Z and Jabbari E:
Mammalian PER2 regulates AKT activation and DNA damage response.
Biochem Cell Biol. 90:675–682. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gotoh T, Kim JK, Liu J, Vila-Caballer M,
Stauffer PE, Tyson JJ and Finkielstein CV: Model-driven
experimental approach reveals the complex regulatory distribution
of p53 by the circadian factor period 2. Proc Natl Acad Sci USA.
113:13516–13521. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Griveau A, Seano G, Shelton SJ, Kupp R,
Jahangiri A, Obernier K, Krishnan S, Lindberg OR, Yuen TJ, Tien AC,
et al: A glial signature and Wnt7 signaling regulate
glioma-vascular interactions and tumor microenvironment. Cancer
Cell. 33:874–889.e7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang N, Wei P, Gong A, Chiu WT, Lee HT,
Colman H, Huang H, Xue J, Liu M, Wang Y, et al: FoxM1 promotes
β-catenin nuclear localization and controls Wnt target-gene
expression and glioma tumorigenesis. Cancer Cell. 20:427–442. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guichet PO, Guelfi S, Teigell M, Hoppe L,
Bakalara N, Bauchet L, Duffau H, Lamszus K, Rothhut B and Hugnot
JP: Notch1 stimulation induces a vascularization switch with
pericyte-like cell differentiation of glioblastoma stem cells. Stem
Cells. 33:21–34. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mikheev AM, Mikheeva SA, Severs LJ, Funk
CC, Huang L, McFaline-Figueroa JL, Schwensen J, Trapnell C, Price
ND, Wong S and Rostomily RC: Targeting TWIST1 through loss of
function inhibits tumorigenicity of human glioblastoma. Mol Oncol.
12:1188–1202. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Di J, Duiveman-de Boer T, Zusterzeel PL,
Figdor CG, Massuger LF and Torensma R: The stem cell markers Oct4A,
Nanog and c-Myc are expressed in ascites cells and tumor tissue of
ovarian cancer patients. Cell Oncol (Dordr). 36:363–374. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim JK and Diehl JA: Nuclear cyclin D1: An
oncogenic driver in human cancer. J Cell Physiol. 220:292–296.
2009. View Article : Google Scholar : PubMed/NCBI
|
